Kairos Pharma (KAPA) Stock Chart & Stock Price History $0.56 -0.02 (-3.09%) As of 05/22/2025 04:10 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartHeadlinesOwnershipSEC FilingsBuy This Stock Kairos Pharma Stock Price Performance The Kairos Pharma (KAPA) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock decreased 63.09%. In the past month, the stock has decreased 34.77%, reflecting recent market activity. As of the latest close, Kairos Pharma traded at $0.56 with a market cap of $7.69 million and volume of 186,419 shares. Receive KAPA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Kairos Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-9.66%1 Month Performance-34.77%3 Month Performance-55.83%Year-To-Date Performance-63.09% KAPA Stock Chart for Friday, May, 23, 2025 KAPA Chart by TradingView Kairos Pharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/22/2025$0.58$0.56-3.09%$0.58$0.53186,419 shs$7.69 million05/21/2025$0.59$0.58-1.88%$0.60$0.57136,980 shs$7.93 million05/20/2025$0.59$0.59-0.17%$0.61$0.5871,891 shs$8.08 million05/19/2025$0.62$0.59-4.83%$0.62$0.58101,039 shs$8.10 million05/16/2025$0.62$0.62+0.98%$0.63$0.6294,992 shs$8.51 million05/15/2025$0.62$0.62-0.81%$0.65$0.58144,088 shs$8.43 million05/14/2025$0.62$0.62-0.02%$0.63$0.57189,473 shs$8.49 million05/13/2025$0.64$0.62-3.11%$0.64$0.60101,522 shs$8.50 million05/12/2025$0.68$0.64-6.03%$0.73$0.58238,046 shs$8.77 million05/09/2025$0.76$0.68-9.79%$0.76$0.6591,470 shs$9.33 million Get the Latest News and Ratings for KAPA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kairos Pharma and its competitors with MarketBeat's FREE daily newsletter. 05/08/2025$0.80$0.76-5.63%$0.80$0.67183,435 shs$10.34 million05/07/2025$0.86$0.80-6.60%$0.86$0.78207,603 shs$10.96 million05/06/2025$0.85$0.86+0.19%$0.89$0.82162,332 shs$11.73 million05/05/2025$0.81$0.85+5.11%$0.86$0.8197,483 shs$11.71 million05/02/2025$0.79$0.81+3.61%$0.84$0.78139,805 shs$11.14 million05/01/2025$0.81$0.79-3.21%$0.84$0.7960,142 shs$10.75 million04/30/2025$0.81$0.81-0.05%$0.85$0.75116,817 shs$11.11 million04/29/2025$0.84$0.81-3.63%$0.87$0.8160,726 shs$11.12 million04/28/2025$0.87$0.84-2.88%$0.87$0.8336,390 shs$11.54 million04/25/2025$0.85$0.87+1.64%$0.89$0.8449,876 shs$11.88 million04/24/2025$0.86$0.85-0.81%$0.88$0.82126,718 shs$11.69 million04/23/2025$0.89$0.86-3.89%$0.89$0.80205,261 shs$11.78 million04/22/2025$0.91$0.89-1.90%$0.94$0.85136,785 shs$12.26 million Related Companies Tenaya Therapeutics Stock Chart Iterum Therapeutics Stock Chart LAVA Therapeutics Stock Chart MariMed Stock Chart Rani Therapeutics Stock Chart FibroBiologics Stock Chart Ayr Wellness Stock Chart Coeptis Therapeutics Stock Chart Dyadic International Stock Chart Scilex Stock Chart Receive KAPA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Kairos Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (NYSEAMERICAN:KAPA) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kairos Pharma, LTD. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kairos Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy KAPA Stock Free KAPA Stock Alerts